Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126183531 | 12618353 | 1 | I | 20160719 | 20160803 | 20160803 | EXP | US-CONCORDIA PHARMACEUTICALS INC.-CO-PL-US-2016-413 | CONCORDIA | GUPTA A,AYYAR B,ZIA H,CHEN W,HARRIS S,NAINA H. HYALINE-VASCULAR TYPE CASTLEMAN^S DISEASE, SARCOIDOSIS, AND CROHNS DISEASE. INDIAN J HEMATOL BLOOD TRANSFUS. 2016 JUN 01;32:S335-S339. | 51.00 | YR | F | Y | 0.00000 | 20160803 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126183531 | 12618353 | 1 | PS | HYDROXYCHLOROQUINE SULFATE. | HYDROXYCHLOROQUINE SULFATE | 1 | Unknown | 9768 | |||||||||||
| 126183531 | 12618353 | 2 | SS | PREDNISONE. | PREDNISONE | 1 | Unknown | 0 | |||||||||||
| 126183531 | 12618353 | 3 | SS | AZATHIOPRINE. | AZATHIOPRINE | 1 | Unknown | 0 | |||||||||||
| 126183531 | 12618353 | 4 | SS | FLUTICASONE/SALMETEROL | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | Unknown | 0 | |||||||||||
| 126183531 | 12618353 | 5 | SS | INFLIXIMAB | INFLIXIMAB | 1 | Unknown | 0 | /month | ||||||||||
| 126183531 | 12618353 | 6 | C | IBUPROFEN. | IBUPROFEN | 1 | 0 | ||||||||||||
| 126183531 | 12618353 | 7 | C | LOPERAMIDE | LOPERAMIDE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126183531 | 12618353 | 1 | Product used for unknown indication |
| 126183531 | 12618353 | 2 | Crohn's disease |
| 126183531 | 12618353 | 3 | Crohn's disease |
| 126183531 | 12618353 | 4 | Product used for unknown indication |
| 126183531 | 12618353 | 5 | Crohn's disease |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126183531 | 12618353 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126183531 | 12618353 | Castleman's disease | |
| 126183531 | 12618353 | Granuloma | |
| 126183531 | 12618353 | Histology abnormal | |
| 126183531 | 12618353 | Lymphadenopathy mediastinal | |
| 126183531 | 12618353 | Night sweats | |
| 126183531 | 12618353 | Obstructive airways disorder | |
| 126183531 | 12618353 | Retroperitoneal mass |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |